Huntsman Cancer Institute contributed to two research studies involving how microbes living in and on our body play a role in the development of colorectal cancer.
We can only imagine how hard it must be for patients, along with their caregivers and loved ones, to hear they have cancer. Our shared purpose is to make it...
Huntsman Cancer Institute's CEO, Mary Beckerle, PhD, and Senior Director of Pre-Clinical Translation, Martin McMahon, PhD, have been appointed to prominent national advisory boards within the National Institutes of Health...
Faculty at Huntsman Cancer Institute cultivate the scientists who will carry our lifesaving work into the future. It’s part of our mission. We offer trainee programs for researchers, public health...
The Precision Exercise Prescription study is a unique collaboration between medical doctors, researchers, physical therapists, and patients. The study looks at how an exercise program tailored for each patient can...
In 2018, a team of researchers at Huntsman Cancer Institute received a prestigious National Cancer Institute Cancer Moonshot grant. The grant will fund studies about ways to identify patients who...
Cornelia Ulrich, PhD, executive director of the Comprehensive Cancer Center at HCI, explains how HCI's community of highly motivated and dedicated researchers, staff, and trainees is focused on one thing...
In less than three years, HCI researchers have taken an idea from concept to lab to clinical evaluation. Conan Kinsey, MD, PhD, and Martin McMahon, PhD, combined two drugs that...
The American Society of Clinical Oncology recently published Clinical Cancer Advances, their 2019 annual report on the progress against cancer. The report examines the most transformative research of the past...
HCI established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Thomas Varghese Jr, MD, MS, was recently honored with a Huntsman Translational Scholar...
